Biopsy Devices Market Top Players - Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopsy Devices Market- (By Product Type (Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), Consumables (Forceps, Trocars, Trays, Other Consumables), By Biopsy Type (Tissue Biopsy (Needle Biopsy, Surgical Biopsy, Skin Biopsy), Liquid Biopsy), By Anatomy (Breast, Lung, Bone, Liver, Uterus/Cervix, Abdomen, Prostate, Cardiac, Skin, Others), By Disease Type (Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, Others), By Guidance Technique (Growth-Share Analysis, Ultrasound-Guided Biopsy, X-Ray-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Biopsy Devices Market is valued at USD 6.84 Bn in 2023, and it is expected to reach US$ 20.04 Bn by 2031, with a CAGR of 14.51% during the forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2228

A biopsy is a critical diagnostic procedure involving the extraction of tissue samples for the identification of various medical conditions, particularly cancer. In cases where malignancy is suspected, biopsies are conducted to obtain tissue specimens for detailed pathological examination. Multiple techniques are employed for cancer diagnosis, including skin biopsy, vacuum-assisted biopsy, incision and excision biopsy, fine needle aspiration, core needle biopsy, and shave biopsy.

The global increase in cancer incidence, including prevalent forms such as breast, prostate, and lung cancer, has significantly intensified the demand for advanced diagnostic and therapeutic solutions. This surge has concurrently heightened awareness regarding available screening and diagnostic procedures. Technological advancements in biopsy methodologies-such as 3D optical biopsies, MRI-targeted biopsies, and ultrasound-guided systems-are enhancing the precision and efficiency of cancer detection.

Furthermore, the growing focus on the early diagnosis of chronic diseases is accelerating the adoption of sophisticated biopsy technologies, including stereotactic-guided systems. The wide range of clinical applications for biopsy devices is anticipated to drive substantial market growth over the forecast period.

List of Prominent Players in the Biopsy Devices Market:
• Argon Medical Devices, Inc.
• B. Braun SE
• Becton
• Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group Incorporated
• Conmed Corporation
• FUJIFILM Holdings Corporation
• GE Healthcare
• Inrad, Inc.
• Medtronic plc
• Olympus Corporation
• Siemens Healthineers AG
• Stryker Corporation
• Zamar Care
• Changzhou Jiuhong Medical Instrument Co., Ltd.
• Kindly (KDL) Meditech
• Ningbo Xinwell Medical Technology Co., LTD.
• Shenzhen Manners Technology Co., Ltd.
• Zhejiang Soudon Medical Technology Co., Ltd
• Agilent Technologies, Inc.
• BGI Group
• Biocept, Inc.
• Bio-Rad Laboratories, Inc.
• Dxcover Limited
• Elypta Limited
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Micronoma
• QIAGEN
• Revvity, Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The biopsy device market is witnessing notable expansion, propelled by multiple factors including technological advancements, evolving regulatory frameworks, and the increasing global burden of chronic diseases. A particularly significant driver is the escalating incidence of cancer worldwide. According to projections from GLOBOCAN, global cancer cases are anticipated to reach 19.3 million by 2025, up from the same number reported in 2020. In the United States, cancer remains the second leading cause of mortality, accounting for approximately one in every four deaths. The American Cancer Society estimated that more than 1.68 million new cancer cases would be diagnosed in 2017, accompanied by approximately 600,920 cancer-related deaths-equivalent to roughly 1,650 deaths per day. This rising cancer prevalence is a major contributor to the increasing demand for biopsy devices, as early and accurate diagnosis becomes critical.

Challenges:
Despite the promising growth trajectory, the biopsy device market faces several challenges. High procurement and maintenance costs associated with advanced biopsy equipment can pose barriers to adoption, particularly in cost-sensitive healthcare environments. Furthermore, clinical complexities related to certain biopsy procedures-such as core needle biopsies-along with heightened scrutiny over the risks associated with breast cancer screenings, may constrain market progression. The invasive nature of biopsy procedures, which often require tissue extraction via incisions, introduces a risk of post-operative infections. Such safety concerns may impede wider acceptance and utilization of biopsy technologies.

Regional Trends:
North America is projected to retain a dominant position in the global biopsy device market, supported by a well-established healthcare system, the availability of trained medical personnel, and the presence of leading market participants. The region is expected to register a strong compound annual growth rate (CAGR) over the forecast period. Meanwhile, the Asia-Pacific region is poised for significant growth, driven by a large and aging population, increasing disposable income, and growing public awareness of disease screening programs. The higher prevalence of cancer in elderly populations across the region is expected to further augment the demand for biopsy devices, making Asia-Pacific a key emerging market in this sector.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2228

Recent Developments:
• In Sept 2023, A revolutionary collaboration has been declared between Roche France, Foundation Medicine, and the Institute Gustave Roussy to provide cancer patients in France with in-house liquid biopsy genomic testing. By transferring FoundationOne®Liquid CDx technology to the Institute Gustave Roussy, Roche France and Foundation Medicine have the potential to provide liquid biopsy testing for comprehensive genomic profiling (CGP) in all patients in France diagnosed with advanced cancer.
• In August 2022, Mammotome announced the release of the Mammotome DualCoreTM biopsy system, the company's first twin-stage core biopsy tool. This novel core biopsy device adds to the Mammotome ultrasound-guided breast biopsy portfolio, which already includes the Mammotome® Elite Tetherless Vacuum-Assisted Biopsy Device (tetherless VABB) and the Mammotome RevolveTM Dual Vacuum-Assisted Breast Biopsy System (tethered VABB).

Segmentation of Biopsy Devices Market-
By Product Type-
• Needle Biopsy Devices
o Guidance Systems
o Biopsy Consoles
o Site Markers
o Biopsy Guns
 Automated Systems
 Semi-Automated Systems
o Needles
• Skin Biopsy Devices
o Punch Biopsy Instruments
o Shave Biopsy Instruments
• Consumables
o Forceps
o Trocars
o Trays
o Other Consumables
By Biopsy Type
• Tissue Biopsy
o Needle Biopsy
o Surgical Biopsy
o Skin Biopsy
• Liquid Biopsy
By Anatomy-
• Breast
• Lung
• Bone
• Liver
• Uterus/Cervix
• Abdomen
• Prostate
• Cardiac
• Skin
• Others
By Disease Type-
• Cancer
• Infections
• Autoimmune Disorders
• Non-Cancerous Indications
• Others
By Guidance Technique -
• Growth-Share Analysis
• Ultrasound-Guided Biopsy
• X-Ray-Guided Biopsy
• MRI-Guided Biopsy
• CT-Guided Biopsy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/biopsy-devices-market/2228

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.